Philip Morris CR A.S. (TABAK) Fair Value & Analysis
Consumer Defensive · CZ · Market cap 51.2B CZK (≈ $2.5B) · ISIN CS0008418869
What is Philip Morris CR A.S. really worth?
A strong business, trading 19% below our fair value of 23,215 CZK.
Strengths
Risks
Fair value as of: Sep 1, 2026
From 23 valuation models · updated 4 days ago
Share price +1.0% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits in the lower half of our model range, the side with the larger margin of safety.
- Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 1, 2026.
How to read this chart
60‑month range 9,780 CZK – 19,122 CZK · fair‑value band 17,411 CZK – 29,019 CZK · the 18,840 CZK price screens below the 23,215 CZK fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 1, 2026.
Analysis
Philip Morris CR A.S. (TABAK) currently trades at 18,840 CZK, while our model-based Fair Value estimate is 23,215 CZK, implying the stock looks roughly 18.8% undervalued today. The Quality Score stands at 85/100 (high quality), in the Consumer Defensive sector. Bull case: the DCF Models group reads highest at a median of 39,115 CZK per share, and 13 of the 23 models we run sit above the 18,840 CZK price. Bear case: the Economic Profit group reads lowest at 11,703 CZK, and 10 of the 23 models stay below the price. Evidence for this calculation is medium.
Over the trailing twelve months, Philip Morris CR A.S. generated revenue of 21.7B CZK at a net margin of 14.0%. Revenue declined 2.0% year over year. It earns a return on equity of 36.3%. The stock trades on a trailing P/E of 17.0. Fundamentals as of Sep 1, 2026
Our scenario range runs from 17,411 CZK (bear case) to 29,019 CZK (bull case); at 18,840 CZK, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 1% below its 52-week high and 15% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at −18% fair-value upside, at 23%, TABAK screens cheaper than that median.
Fair Value models
This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly 751.95 CZK per share, which is 3.2 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 23 models by family
Widest divergence: DCF Models (39,115 CZK) versus Asset-Based (2,004 CZK). Highest evidence: FCF DCF (79).
Notify me when TABAK reaches fair value
Put TABAK on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Sep 1, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 84 · Market factors (momentum, volatility) 67
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Philip Morris CR a.s., through its subsidiary, Philip Morris Slovakia s.r.o., manufactures and markets tobacco products under the Marlboro, L&M, Philip Morris, Petra Klasik, and Sparta brands in the Czech Republic, the Slovak Republic, and internationally.
Full company description
Philip Morris CR a.s., through its subsidiary, Philip Morris Slovakia s.r.o., manufactures and markets tobacco products under the Marlboro, L&M, Philip Morris, Petra Klasik, and Sparta brands in the Czech Republic, the Slovak Republic, and internationally. It offers cigarettes and smoke-free products, including heated tobacco, e-vapor, and oral smokeless products. The company was founded in 1812 and is based in Prague, the Czech Republic. Philip Morris CR a.s. operates as a subsidiary of Philip Morris Holland Holdings B.V.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Philip Morris CR A.S. reported revenue of 21.7B CZK in FY2025 versus 18.9B CZK in FY2021, a compound +3.5%/yr. Reported net income was 3.0B CZK in FY2025, compounding −3.6%/yr from FY2021.
Watch TABAK: get an alert when its fair value changes →
Peer Group
Tobacco · 36 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Tobacco median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 45/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Tobacco stocks, each showing price versus our Fair Value estimate (as of Sep 1, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| British American Tobacco p.l.c. BTI | $56.13 | $61.07 | +9% |
| Altria Group MO | $68.65 | $81.81 | +19% |
| ITC Limited 500875 | ₹279.50 | ₹212.74 | −24% |
| KT&G Corporation 033780 | 175,500 KRW | 110,656 KRW | −37% |
| PT Hanjaya Mandala Sampoerna Tbk, HMSP | 745.00 IDR | 1,041 IDR | +40% |
| Smoore International Holdings 6969 | HK$9.24 | HK$4.19 | −55% |
| Godfrey Phillips India Limited GODFRYPHLP | ₹2,160 | ₹1,194 | −45% |
| PT Gudang Garam Tbk, GGRM | 20,675 IDR | 16,988 IDR | −18% |
| China Tobacco International (HK) Company 6055 | HK$23.86 | HK$24.09 | +1% |
| Turning Point Brands, Inc TPB | $85.80 | $44.89 | −48% |
Compare Philip Morris CR A.S. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Philip Morris CR A.S. (TABAK) overvalued or undervalued?
What is the fair value of TABAK?
What is the quality score of TABAK?
What is the revenue of Philip Morris CR A.S. (TABAK)?
What is the net profit margin of TABAK?
Watch Philip Morris CR A.S. in the live analysis
One click puts Philip Morris CR A.S. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.